Correction to: Cancer Gene Therapy (2024); https://doi.org/10.1038/s41417-024-00818-z, published on 09 August 2024
In this article the statement in the Funding information section was incorrectly given as ‘This work was supported by the National Natural Science Foundation of China (82100154, 82200245, 82104447, and 82270175), the Open Project Program of the National Research Center for Translational Medicine at Shanghai (TMSZ-2020-204 and NRCTM(SH)-2021-09), the Natural Science Foundation of Fujian Province of China (2021J02040), and the Joint Funds for the Innovation of Science and Technology of Fujian Province (2023Y9173).’ and should have read ‘This work was supported by the National Natural Science Foundation of China (82470154, 82100154, 82200245, 82104447, and 82270175), the Open Project Program of the National Research Center for Translational Medicine at Shanghai (TMSZ-2020-204 and NRCTM(SH)-2021-09), the Natural Science Foundation of Fujian Province of China (2021J02040), the Joint Funds for the Innovation of Science and Technology of Fujian Province (2023Y9173), the Collaborative Innovation Center of Hematology, and the Samuel Waxman Cancer Research Foundation.’. The original article has been corrected.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Xie, S., Liu, H., Zhu, S. et al. Correction: Arsenic trioxide and p97 inhibitor synergize against acute myeloid leukemia by targeting nascent polypeptides and activating the ZAKα–JNK pathway. Cancer Gene Ther 31, 1750 (2024). https://doi.org/10.1038/s41417-024-00848-7
Published:
Issue date:
DOI: https://doi.org/10.1038/s41417-024-00848-7
